Vitestro
Vitestro is a medical robotics company that specializes in autonomous blood drawing technology. The company develops an innovative device that automates the entire blood collection process, utilizing AI-based ultrasound-guided 3D imaging and robotic needle insertion. This technology aims to enhance patient care and streamline clinical workflows in hospitals across Europe and beyond. The flagship product boasts a high first-stick success rate of 95% and a low haemolysis rate of 0.6%, making it comparable to traditional manual phlebotomy. The median procedure time is approximately 1 minute and 49 seconds, significantly faster than the typical 5-minute manual blood draw. Vitestro collaborates with leading European hospitals and laboratories for clinical development, with over 2,000 patients participating in trials to validate the device's safety and efficacy. The company also partners with Northwestern Medicine in the U.S. to advance the adoption of autonomous robotic phlebotomy in healthcare settings.
Work at Vitestro in HR or recruiting? Claim this page
Headcount trend
Vitestro went from 8 employees in Oct 2024 to 9 in Sep 2026. Apr to Sep 2026: 1 people joined, 0 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Apr 2024 | Funding | $22M | 3 | |
| Mar 2023 | Series A | $12.9M | 1 |
Org structure
Headcount by department
Peer reviews
Worked with someone at Vitestro?
Anonymous peer reviews on OffTheRecord
Similar companies
Vitestro FAQ
How many employees does Vitestro have?
Vitestro has about 9 employees, unchanged over the 3 months to Sep 2026.
What is Vitestro's revenue per employee?
Vitestro makes about $3.84M in revenue per employee, based on $34.6M annual revenue and 9 employees.
How much funding has Vitestro raised?
Vitestro has raised $34.86M in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.